InspireMD Ownership
| NSPR Stock | USD 3.00 0.02 0.67% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 36 M | Current Value 48 M | Avarage Shares Outstanding 16.4 M | Quarterly Volatility 13.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
InspireMD |
InspireMD Stock Ownership Analysis
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InspireMD recorded a loss per share of 0.71. The entity last dividend was issued on the 1st of April 2019. The firm had 1:15 split on the 27th of April 2021. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Inspiremd operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people. To find out more about InspireMD contact Marvin Slosman at 972 3 6917691 or learn more at https://www.inspiremd.com.Besides selling stocks to institutional investors, InspireMD also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different InspireMD's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align InspireMD's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
InspireMD Quarterly Liabilities And Stockholders Equity |
|
InspireMD Insider Trades History
About 17.0% of InspireMD are currently held by insiders. Unlike InspireMD's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against InspireMD's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of InspireMD's insider trades
InspireMD Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as InspireMD is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InspireMD backward and forwards among themselves. InspireMD's institutional investor refers to the entity that pools money to purchase InspireMD's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Elias Asset Management Inc | 2024-09-30 | 30 K | Mesirow Fin Investmt Mgmt Intl Equity | 2024-09-30 | 30 K | Northern Trust Corp | 2024-09-30 | 23.6 K | Hollencrest Securities, Llc | 2024-09-30 | 20 K | Geode Capital Management, Llc | 2024-09-30 | 18.2 K | Avestar Capital, Llc | 2024-09-30 | 15 K | Schonfeld Strategic Advisors Llc | 2024-09-30 | 11.9 K | Mckinley Carter Wealth Services Inc | 2024-09-30 | 10 K | Advisornet Financial, Inc | 2024-09-30 | 8.8 K | Rosalind Advisors, Inc. | 2024-09-30 | 2.5 M | Nantahala Capital Management, Llc | 2024-09-30 | 2.2 M |
InspireMD Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases InspireMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Craig Shore over three months ago Acquisition by Craig Shore of 72978 shares of InspireMD subject to Rule 16b-3 | ||
Kester Thomas J over three months ago Acquisition by Kester Thomas J of 11098 shares of InspireMD at 3.14 subject to Rule 16b-3 | ||
Berman Michael over six months ago Disposition of 61249 shares by Berman Michael of InspireMD at 1.3827 subject to Rule 16b-3 | ||
Stuka Paul over six months ago Disposition of 87500 shares by Stuka Paul of InspireMD at 1.3827 subject to Rule 16b-3 | ||
Paul Stuka over six months ago Acquisition by Paul Stuka of 43548 shares of InspireMD subject to Rule 16b-3 | ||
Verta Patrick over a year ago InspireMD exotic insider transaction detected | ||
Paul Stuka over a year ago Acquisition by Paul Stuka of 238950 shares of InspireMD subject to Rule 16b-3 | ||
Paul Stuka over a year ago Acquisition by Paul Stuka of 225680 shares of InspireMD subject to Rule 16b-3 |
InspireMD Outstanding Bonds
InspireMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. InspireMD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most InspireMD bonds can be classified according to their maturity, which is the date when InspireMD has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Iris Merger Sub Corp BondUS45774NAB47 | View |
InspireMD Corporate Filings
8K | 12th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of December 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F3 | 27th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 14th of November 2024 Other Reports | ViewVerify |
Pair Trading with InspireMD
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.Moving together with InspireMD Stock
Moving against InspireMD Stock
| 0.63 | ENSG | Ensign Group | PairCorr |
| 0.62 | DRIO | DarioHealth Corp | PairCorr |
| 0.6 | EDAP | EDAP TMS SA | PairCorr |
| 0.49 | VTAK | Catheter Precision | PairCorr |
| 0.49 | EKSO | Ekso Bionics Holdings | PairCorr |
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.